| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.931 | 0.001 | 0.931 | 5 Hydroxytryptamine release stimulant | 0.853 0.003 CID_17005 | ||
| 0.869 | 0.003 | 0.869 | Psychostimulant | 0.663 0.005 CID_17005 | ||
| 0.564 | 0.003 | 0.798 | 5 Hydroxytryptamine uptake stimulant | 0.798 0.001 CID_17005 | CID_17005 | |
| 0.544 | 0.046 | 0.544 | Caspase 9 stimulant | 0.504 0.058 CID_17005 | ||
| 0.496 | 0.024 | 0.496 | Spasmolytic | 0.479 0.026 CID_17005 | ||
| 0.471 | 0.02 | 0.471 | Vasodilator, coronary | 0.426 0.028 CID_17005 | ||
| 0.484 | 0.038 | 0.58 | 5 Hydroxytryptamine release inhibitor | 0.58 0.014 CID_17005 | CID_17005 | |
| 0.465 | 0.026 | 0.465 | Caspase 3 stimulant | 0.259 0.104 CID_17005 | ||
| 0.38 | 0.007 | 0.38 | Neurotrophic factor enhancer | 0.318 0.014 CID_17005 | ||
| 0.429 | 0.057 | 0.528 | Transcription factor NF kappa B inhibitor | 0.528 0.04 CID_17005 | CID_17005 | |
| 0.382 | 0.01 | 0.806 | Tyrosine 3 hydroxylase inhibitor | 0.806 0.002 CID_17005 | CID_17005 | |
| 0.37 | 0.005 | 0.37 | CDC-like kinase 1 inhibitor | |||
| 0.425 | 0.063 | 0.461 | Histamine release inhibitor | 0.461 0.045 CID_17005 | CID_17005 | |
| 0.345 | 0.002 | 0.345 | DOPA decarboxylase inhibitor | 0.333 0.002 CID_17005 | ||
| 0.345 | 0.003 | 0.345 | CDC-like kinase 3 inhibitor | |||
| 0.336 | 0.004 | 0.336 | Nitric-oxide synthase inhibitor | 0.188 0.012 CID_17005 | ||
| 0.334 | 0.004 | 0.334 | 5 Hydroxytryptamine 3E antagonist | 0.216 0.041 CID_17005 | ||
| 0.334 | 0.007 | 0.334 | 5 Hydroxytryptamine agonist | 0.25 0.011 CID_17005 | ||
| 0.35 | 0.024 | 0.364 | Anesthetic general | 0.364 0.022 CID_17005 | CID_17005 | |
| 0.329 | 0.004 | 0.329 | Inducible nitric-oxide synthase inhibitor | 0.146 0.017 CID_17005 | ||
| 0.33 | 0.032 | 0.33 | Clk dual-specificity kinase inhibitor | |||
| 0.302 | 0.02 | 0.302 | MAO inhibitor | 0.247 0.028 CID_17005 | ||
| 0.336 | 0.071 | 0.457 | Cholesterol antagonist | 0.457 0.039 CID_17005 | CID_17005 | |
| 0.264 | 0.004 | 0.264 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.381 | 0.123 | 0.414 | Apoptosis agonist | 0.414 0.107 CID_17005 | CID_17005 | |
| 0.263 | 0.007 | 0.348 | 5 Hydroxytryptamine 1F antagonist | 0.348 0.005 CID_17005 | CID_17005 | |
| 0.268 | 0.018 | 0.268 | MAO A inhibitor | 0.256 0.02 CID_17005 | ||
| 0.255 | 0.009 | 0.431 | Histidine decarboxylase inhibitor | 0.431 0.004 CID_17005 | CID_17005 | |
| 0.294 | 0.049 | 0.294 | Pyruvate kinase inhibitor | 0.244 0.063 CID_17005 | ||
| 0.247 | 0.007 | 0.247 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.333 | 0.095 | 0.333 | Calpain 2 inhibitor | 0.257 0.145 CID_17005 | ||
| 0.263 | 0.027 | 0.318 | Melanin inhibitor | 0.318 0.02 CID_17005 | CID_17005 | |
| 0.272 | 0.038 | 0.272 | Hepatoprotectant | 0.19 0.072 CID_17005 | ||
| 0.316 | 0.089 | 0.398 | Vasodilator, peripheral | 0.398 0.056 CID_17005 | CID_17005 | |
| 0.23 | 0.005 | 0.35 | Glutamate decarboxylase inhibitor | 0.35 0.003 CID_17005 | CID_17005 | |
| 0.272 | 0.047 | 0.28 | Calpain inhibitor | 0.28 0.041 CID_17005 | CID_17005 | |
| 0.276 | 0.053 | 0.276 | DNA synthesis inhibitor | 0.254 0.064 CID_17005 | ||
| 0.221 | 0.007 | 0.256 | Adenylate cyclase stimulant | 0.256 0.004 CID_17005 | CID_17005 | |
| 0.244 | 0.03 | 0.244 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.111 CID_17005 | ||
| 0.215 | 0.004 | 0.215 | Endothelin receptor antagonist | |||
| 0.236 | 0.029 | 0.236 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.234 | 0.03 | 0.234 | Thiol protease inhibitor | 0.205 0.037 CID_17005 | ||
| 0.294 | 0.092 | 0.382 | Antithrombotic | 0.382 0.054 CID_17005 | CID_17005 | |
| 0.244 | 0.045 | 0.373 | Growth hormone agonist | 0.373 0.02 CID_17005 | CID_17005 | |
| 0.274 | 0.076 | 0.401 | Insulysin inhibitor | 0.401 0.022 CID_17005 | CID_17005 | |
| 0.263 | 0.067 | 0.708 | Superoxide dismutase inhibitor | 0.708 0.004 CID_17005 | CID_17005 | |
| 0.259 | 0.064 | 0.259 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.233 | 0.045 | 0.289 | Insulin sensitizer | 0.289 0.018 CID_17005 | CID_17005 | |
| 0.261 | 0.074 | 0.261 | DNA damaging | 0.22 0.1 CID_17005 | ||
| 0.219 | 0.035 | 0.219 | Acetylcholine M1 receptor antagonist | 0.185 0.049 CID_17005 | ||
| 0.254 | 0.07 | 0.254 | 5 Hydroxytryptamine 1E antagonist | 0.237 0.089 CID_17005 | ||
| 0.192 | 0.009 | 0.192 | CYP2A6 inhibitor | 0.127 0.024 CID_17005 | ||
| 0.252 | 0.071 | 0.252 | Dyrk kinase inhibitor | |||
| 0.252 | 0.076 | 0.252 | Gastrin inhibitor | 0.25 0.079 CID_17005 | ||
| 0.2 | 0.026 | 0.2 | Topoisomerase I inhibitor | |||
| 0.177 | 0.004 | 0.223 | 5 Hydroxytryptamine 2A agonist | 0.223 0.004 CID_17005 | CID_17005 | |
| 0.188 | 0.016 | 0.191 | Interleukin 8 antagonist | 0.191 0.015 CID_17005 | CID_17005 | |
| 0.192 | 0.023 | 0.268 | Aminopeptidase B inhibitor | 0.268 0.011 CID_17005 | CID_17005 | |
| 0.19 | 0.021 | 0.197 | Falcipain 3 inhibitor | 0.197 0.019 CID_17005 | CID_17005 | |
| 0.183 | 0.015 | 0.183 | Papain-like protease (SARS coronavirus) inhibitor | 0.137 0.049 CID_17005 | ||
| 0.171 | 0.007 | 0.171 | Phosphodiesterase 11A inhibitor | |||
| 0.171 | 0.007 | 0.171 | Phosphodiesterase XI inhibitor | |||
| 0.188 | 0.023 | 0.207 | Cyclooxygenase 3 inhibitor | 0.207 0.016 CID_17005 | CID_17005 | |
| 0.169 | 0.005 | 0.184 | GABA aminotransferase inhibitor | 0.184 0.005 CID_17005 | CID_17005 | |
| 0.266 | 0.102 | 0.392 | Interleukin 2 agonist | 0.392 0.03 CID_17005 | CID_17005 | |
| 0.164 | 0.004 | 0.164 | Endothelin A receptor antagonist | |||
| 0.182 | 0.022 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 CID_17005 | CID_17005 | |
| 0.228 | 0.068 | 0.282 | Peptidyltransferase inhibitor | 0.282 0.032 CID_17005 | CID_17005 | |
| 0.194 | 0.035 | 0.194 | Topoisomerase II inhibitor | |||
| 0.163 | 0.003 | 0.163 | Endothelin B receptor antagonist | |||
| 0.217 | 0.059 | 0.217 | CDC-like kinase 4 inhibitor | |||
| 0.172 | 0.016 | 0.183 | Heat shock protein 70 antagonist | 0.183 0.011 CID_17005 | CID_17005 | |
| 0.239 | 0.084 | 0.329 | Hypoglycemic | 0.329 0.043 CID_17005 | CID_17005 | |
| 0.194 | 0.038 | 0.262 | Neurotensin receptor agonist | 0.262 0.019 CID_17005 | CID_17005 | |
| 0.188 | 0.033 | 0.188 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.183 | 0.028 | 0.183 | MAO B inhibitor | 0.133 0.044 CID_17005 | ||
| 0.198 | 0.045 | 0.363 | Phospholipase C inhibitor | 0.363 0.013 CID_17005 | CID_17005 | |
| 0.169 | 0.022 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 CID_17005 | CID_17005 | |
| 0.188 | 0.049 | 0.188 | Interleukin 6 antagonist | 0.167 0.067 CID_17005 | ||
| 0.171 | 0.034 | 0.171 | Acetylcholine muscarinic antagonist | 0.126 0.061 CID_17005 | ||
| 0.171 | 0.035 | 0.171 | Cell adhesion inhibitor | 0.13 0.058 CID_17005 | ||
| 0.236 | 0.102 | 0.37 | Immunostimulant | 0.37 0.059 CID_17005 | CID_17005 | |
| 0.168 | 0.035 | 0.215 | Cathepsin H inhibitor | 0.215 0.019 CID_17005 | CID_17005 | |
| 0.16 | 0.029 | 0.227 | Vanilloid 1 agonist | 0.227 0.007 CID_17005 | CID_17005 | |
| 0.142 | 0.014 | 0.155 | Ornithine decarboxylase inhibitor | 0.155 0.01 CID_17005 | CID_17005 | |
| 0.168 | 0.042 | 0.185 | Anesthetic local | 0.185 0.036 CID_17005 | CID_17005 | |
| 0.129 | 0.004 | 0.129 | Glutamate (mGluR7) antagonist | 0.09 0.017 CID_17005 | ||
| 0.145 | 0.021 | 0.145 | Factor V inhibitor | 0.122 0.037 CID_17005 | ||
| 0.138 | 0.015 | 0.213 | Aminopeptidase I inhibitor | 0.213 0.006 CID_17005 | CID_17005 | |
| 0.181 | 0.059 | 0.205 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.205 0.049 CID_17005 | CID_17005 | |
| 0.124 | 0.005 | 0.145 | 5 Hydroxytryptamine 2C agonist | 0.145 0.005 CID_17005 | CID_17005 | |
| 0.203 | 0.084 | 0.316 | Nitric-oxide synthase stimulant | 0.316 0.008 CID_17005 | CID_17005 | |
| 0.144 | 0.03 | 0.144 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.186 | 0.074 | 0.186 | CDC-like kinase 2 inhibitor | |||
| 0.152 | 0.04 | 0.152 | 5 Hydroxytryptamine 2B antagonist | 0.125 0.056 CID_17005 | ||
| 0.205 | 0.096 | 0.433 | Antiamyloidogenic | 0.433 0.024 CID_17005 | CID_17005 | |
| 0.116 | 0.007 | 0.116 | 5 Hydroxytryptamine 2 agonist | 0.11 0.008 CID_17005 | ||
| 0.118 | 0.01 | 0.118 | Protease 3C (Human rhinovirus) inhibitor | 0.101 0.015 CID_17005 | ||
| 0.174 | 0.066 | 0.174 | ATPase inhibitor | 0.174 0.065 CID_17005 | ||
| 0.207 | 0.1 | 0.221 | Vasodilator | 0.221 0.089 CID_17005 | CID_17005 | |
| 0.123 | 0.018 | 0.123 | Phosphodiesterase V inhibitor | |||
| 0.145 | 0.041 | 0.145 | Alpha 2b adrenoreceptor antagonist | 0.095 0.079 CID_17005 | ||
| 0.121 | 0.018 | 0.622 | Phenylalanine 4-hydroxylase inhibitor | 0.622 0.002 CID_17005 | CID_17005 | |
| 0.14 | 0.039 | 0.217 | Mucolytic | 0.217 0.01 CID_17005 | CID_17005 | |
| 0.133 | 0.032 | 0.254 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.254 0.009 CID_17005 | CID_17005 | |
| 0.129 | 0.03 | 0.129 | Calcium antagonist | |||
| 0.224 | 0.126 | 0.266 | 12-Lipoxygenase inhibitor | 0.266 0.1 CID_17005 | CID_17005 | |
| 0.145 | 0.048 | 0.238 | Adenylate cyclase inhibitor | 0.238 0.02 CID_17005 | CID_17005 | |
| 0.151 | 0.054 | 0.298 | Alpha-N-acetylglucosaminidase inhibitor | 0.298 0.016 CID_17005 | CID_17005 | |
| 0.122 | 0.024 | 0.122 | Transcription factor NF kappa B stimulant | 0.093 0.046 CID_17005 | ||
| 0.155 | 0.058 | 0.199 | Histone deacetylase SIRT1 inhibitor | 0.199 0.031 CID_17005 | CID_17005 | |
| 0.14 | 0.043 | 0.147 | Microtubule formation inhibitor | 0.147 0.039 CID_17005 | CID_17005 | |
| 0.147 | 0.051 | 0.147 | Acetylcholine antagonist | 0.108 0.082 CID_17005 | ||
| 0.148 | 0.053 | 0.148 | Cholinergic antagonist | 0.111 0.083 CID_17005 | ||
| 0.204 | 0.113 | 0.253 | Neuropeptide Y2 antagonist | 0.253 0.053 CID_17005 | CID_17005 | |
| 0.147 | 0.059 | 0.147 | Tubulin antagonist | |||
| 0.195 | 0.107 | 0.257 | RNA-directed DNA polymerase inhibitor | 0.257 0.045 CID_17005 | CID_17005 | |
| 0.109 | 0.023 | 0.109 | Phosphodiesterase 5A inhibitor | |||
| 0.155 | 0.069 | 0.155 | Heat shock protein 90 antagonist | 0.119 0.115 CID_17005 | ||
| 0.111 | 0.025 | 0.197 | Keratolytic | 0.197 0.009 CID_17005 | CID_17005 | |
| 0.113 | 0.029 | 0.221 | Adrenaline agonist | 0.221 0.005 CID_17005 | CID_17005 | |
| 0.088 | 0.004 | 0.088 | Thrombin receptor antagonist | 0.027 0.022 CID_17005 | ||
| 0.088 | 0.005 | 0.088 | Diamine oxidase inhibitor | 0.049 0.015 CID_17005 | ||
| 0.111 | 0.028 | 0.154 | Somatostatin 1 agonist | 0.154 0.013 CID_17005 | CID_17005 | |
| 0.095 | 0.013 | 0.095 | Heat shock protein 90 beta antagonist | 0.07 0.028 CID_17005 | ||
| 0.16 | 0.079 | 0.16 | Sigma receptor agonist | |||
| 0.145 | 0.063 | 0.145 | Bone formation stimulant | 0.134 0.073 CID_17005 | ||
| 0.124 | 0.044 | 0.126 | Protease inhibitor | 0.126 0.043 CID_17005 | CID_17005 | |
| 0.098 | 0.018 | 0.124 | GABA B receptor agonist | 0.124 0.006 CID_17005 | CID_17005 | |
| 0.2 | 0.121 | 0.448 | Interleukin agonist | 0.448 0.013 CID_17005 | CID_17005 | |
| 0.087 | 0.009 | 0.087 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_17005 | ||
| 0.121 | 0.044 | 0.121 | Falcipain inhibitor | 0.094 0.059 CID_17005 | ||
| 0.098 | 0.021 | 0.098 | Cathepsin L inhibitor | 0.054 0.045 CID_17005 | ||
| 0.086 | 0.009 | 0.086 | Kainate receptor antagonist | 0.052 0.02 CID_17005 | ||
| 0.114 | 0.039 | 0.114 | Alpha 2 adrenoreceptor antagonist | |||
| 0.118 | 0.043 | 0.118 | Falcipain 2 inhibitor | 0.091 0.059 CID_17005 | ||
| 0.121 | 0.049 | 0.265 | GABA C receptor agonist | 0.265 0.012 CID_17005 | CID_17005 | |
| 0.088 | 0.017 | 0.104 | Glutamate (mGluR6) antagonist | 0.104 0.009 CID_17005 | CID_17005 | |
| 0.152 | 0.081 | 0.238 | Thrombolytic | 0.238 0.037 CID_17005 | CID_17005 | |
| 0.202 | 0.131 | 0.32 | Transcription factor STAT3 inhibitor | 0.32 0.044 CID_17005 | CID_17005 | |
| 0.149 | 0.079 | 0.639 | Peroxidase inhibitor | 0.639 0.004 CID_17005 | CID_17005 | |
| 0.097 | 0.029 | 0.097 | Alpha adrenoreceptor agonist | 0.093 0.031 CID_17005 | ||
| 0.074 | 0.005 | 0.074 | 5 Hydroxytryptamine 2B agonist | 0.073 0.005 CID_17005 | ||
| 0.081 | 0.012 | 0.081 | Cathepsin L1 inhibitor | |||
| 0.077 | 0.008 | 0.077 | Histamine H2 receptor agonist | 0.054 0.018 CID_17005 | ||
| 0.117 | 0.049 | 0.252 | Carbonic anhydrase XV inhibitor | 0.252 0.012 CID_17005 | CID_17005 | |
| 0.074 | 0.007 | 0.074 | Plasmepsin II inhibitor | 0.045 0.022 CID_17005 | ||
| 0.126 | 0.06 | 0.126 | DNA repair enzyme inhibitor | 0.11 0.095 CID_17005 | ||
| 0.074 | 0.01 | 0.074 | Mannosidase inhibitor | 0.053 0.023 CID_17005 | ||
| 0.095 | 0.031 | 0.196 | Opioid delta receptor antagonist | 0.196 0.012 CID_17005 | CID_17005 | |
| 0.141 | 0.079 | 0.156 | Neuropeptide Y1 antagonist | 0.156 0.057 CID_17005 | CID_17005 | |
| 0.081 | 0.019 | 0.081 | Alpha tubulin antagonist | 0.047 0.044 CID_17005 | ||
| 0.098 | 0.036 | 0.152 | Vanilloid agonist | 0.152 0.01 CID_17005 | CID_17005 | |
| 0.17 | 0.108 | 0.262 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.262 0.037 CID_17005 | CID_17005 | |
| 0.105 | 0.044 | 0.189 | Opioid antagonist | 0.189 0.016 CID_17005 | CID_17005 | |
| 0.068 | 0.008 | 0.068 | AMPA 4 receptor antagonist | 0.054 0.013 CID_17005 | ||
| 0.082 | 0.023 | 0.082 | Exportin-1 inhibitor | |||
| 0.118 | 0.059 | 0.118 | DNA intercalator | |||
| 0.174 | 0.117 | 0.191 | Cyclic AMP phosphodiesterase inhibitor | 0.191 0.1 CID_17005 | CID_17005 | |
| 0.076 | 0.019 | 0.076 | AMPA receptor antagonist | |||
| 0.167 | 0.11 | 0.167 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.067 | 0.01 | 0.067 | Glutamate (mGluR group III) antagonist | 0.054 0.017 CID_17005 | ||
| 0.234 | 0.179 | 0.255 | 15-Lipoxygenase inhibitor | 0.255 0.161 CID_17005 | CID_17005 | |
| 0.108 | 0.053 | 0.289 | Carbonic anhydrase III inhibitor | 0.289 0.006 CID_17005 | CID_17005 | |
| 0.135 | 0.08 | 0.159 | Cell wall synthesis inhibitor | 0.159 0.057 CID_17005 | CID_17005 | |
| 0.096 | 0.042 | 0.096 | Factor XII inhibitor | 0.089 0.051 CID_17005 | ||
| 0.08 | 0.027 | 0.08 | Adrenaline uptake inhibitor | 0.072 0.033 CID_17005 | ||
| 0.101 | 0.049 | 0.101 | Phosphodiesterase 6D inhibitor | |||
| 0.152 | 0.1 | 0.152 | Catenin beta inhibitor | 0.152 0.102 CID_17005 | ||
| 0.065 | 0.013 | 0.065 | Factor III inhibitor | 0.05 0.034 CID_17005 | ||
| 0.078 | 0.026 | 0.162 | Argininosuccinate synthase inhibitor | 0.162 0.01 CID_17005 | CID_17005 | |
| 0.087 | 0.037 | 0.166 | Opioid mu receptor antagonist | 0.166 0.014 CID_17005 | CID_17005 | |
| 0.109 | 0.06 | 0.221 | Expectorant | 0.221 0.016 CID_17005 | CID_17005 | |
| 0.093 | 0.044 | 0.093 | Topoisomerase II alpha inhibitor | |||
| 0.104 | 0.055 | 0.133 | Sphingomyelinase inhibitor | 0.133 0.033 CID_17005 | CID_17005 | |
| 0.068 | 0.02 | 0.068 | Ryanodine receptor antagonist | |||
| 0.092 | 0.044 | 0.092 | mTOR complex 2 inhibitor | |||
| 0.075 | 0.028 | 0.075 | Alpha 2 adrenoreceptor agonist | 0.058 0.045 CID_17005 | ||
| 0.075 | 0.029 | 0.11 | Protein kinase C iota inhibitor | 0.11 0.016 CID_17005 | CID_17005 | |
| 0.09 | 0.044 | 0.09 | Chymotrypsin inhibitor | 0.09 0.043 CID_17005 | ||
| 0.142 | 0.096 | 0.142 | Heat shock protein 90 alpha antagonist | 0.137 0.102 CID_17005 | ||
| 0.054 | 0.01 | 0.088 | Kainate receptor agonist | 0.088 0.003 CID_17005 | CID_17005 | |
| 0.119 | 0.075 | 0.149 | Sphingosine 1-phosphate receptor 4 antagonist | 0.149 0.034 CID_17005 | CID_17005 | |
| 0.094 | 0.051 | 0.094 | Antineoplastic alkaloid | |||
| 0.091 | 0.048 | 0.11 | Myeloperoxidase inhibitor | 0.11 0.026 CID_17005 | CID_17005 | |
| 0.092 | 0.052 | 0.092 | ATPase (Vacuolar H+) inhibitor | |||
| 0.089 | 0.048 | 0.089 | 3C-Like protease (SARS coronavirus) inhibitor | 0.082 0.063 CID_17005 | ||
| 0.158 | 0.118 | 0.362 | Angiogenesis stimulant | 0.362 0.029 CID_17005 | CID_17005 | |
| 0.067 | 0.027 | 0.104 | Beta 2 adrenoreceptor agonist | 0.104 0.004 CID_17005 | CID_17005 | |
| 0.069 | 0.03 | 0.069 | Cathepsin E inhibitor | 0.062 0.038 CID_17005 | ||
| 0.082 | 0.043 | 0.161 | Glutamate dehydrogenase inhibitor | 0.161 0.014 CID_17005 | CID_17005 | |
| 0.062 | 0.026 | 0.062 | Protease activated receptor 1 antagonist | |||
| 0.067 | 0.033 | 0.07 | Histone deacetylase SIRT3 inhibitor | 0.07 0.027 CID_17005 | CID_17005 | |
| 0.05 | 0.017 | 0.173 | Dopamine D5 agonist | 0.173 0.002 CID_17005 | CID_17005 | |
| 0.109 | 0.076 | 0.183 | Proteasome inhibitor | 0.183 0.031 CID_17005 | CID_17005 | |
| 0.064 | 0.032 | 0.064 | Human rhinovirus A protease inhibitor | 0.06 0.035 CID_17005 | ||
| 0.059 | 0.027 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.078 0.007 CID_17005 | CID_17005 | |
| 0.087 | 0.057 | 0.147 | Granulocyte macrophage colony stimulating factor agonist | 0.147 0.005 CID_17005 | CID_17005 | |
| 0.067 | 0.036 | 0.067 | I kappa B kinase 2 inhibitor | |||
| 0.057 | 0.027 | 0.059 | Dopamine transporter inhibitor | 0.059 0.025 CID_17005 | CID_17005 | |
| 0.066 | 0.037 | 0.119 | Carbamoyl phosphate synthetase inhibitor | 0.119 0.016 CID_17005 | CID_17005 | |
| 0.102 | 0.073 | 0.16 | Nav1.4 sodium channel blocker | 0.16 0.03 CID_17005 | CID_17005 | |
| 0.041 | 0.012 | 0.041 | Dipeptidyl peptidase I inhibitor | 0.036 0.015 CID_17005 | ||
| 0.098 | 0.07 | 0.151 | Adenylate kinase inhibitor | 0.151 0.026 CID_17005 | CID_17005 | |
| 0.064 | 0.036 | 0.082 | Bombesin 1 receptor agonist | 0.082 0.024 CID_17005 | CID_17005 | |
| 0.049 | 0.021 | 0.049 | Somatostatin 1 antagonist | 0.047 0.022 CID_17005 | ||
| 0.05 | 0.022 | 0.05 | Phosphodiesterase 6C inhibitor | |||
| 0.048 | 0.021 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 CID_17005 | CID_17005 | |
| 0.052 | 0.026 | 0.052 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.031 | 0.005 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 CID_17005 | ||
| 0.04 | 0.014 | 0.04 | AMPA 3 receptor antagonist | 0.036 0.016 CID_17005 | ||
| 0.056 | 0.031 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 CID_17005 | ||
| 0.077 | 0.053 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | 0.07 0.062 CID_17005 | ||
| 0.052 | 0.028 | 0.123 | Opioid mu receptor agonist | 0.123 0.009 CID_17005 | CID_17005 | |
| 0.066 | 0.042 | 0.066 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.061 | 0.037 | 0.061 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.06 | 0.038 | 0.06 | Dopamine uptake inhibitor | 0.053 0.045 CID_17005 | ||
| 0.033 | 0.011 | 0.033 | Motilin receptor antagonist | 0.031 0.014 CID_17005 | ||
| 0.064 | 0.042 | 0.064 | 5 Hydroxytryptamine 3 agonist | |||
| 0.042 | 0.02 | 0.076 | Glutamate (mGluR8) agonist | 0.076 0.004 CID_17005 | CID_17005 | |
| 0.074 | 0.052 | 0.206 | Catalase inhibitor | 0.206 0.014 CID_17005 | CID_17005 | |
| 0.039 | 0.018 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 CID_17005 | ||
| 0.044 | 0.022 | 0.044 | Melanocortin 1 antagonist | 0.034 0.03 CID_17005 | ||
| 0.065 | 0.045 | 0.084 | Glucagon-like peptide 1 agonist | 0.084 0.032 CID_17005 | CID_17005 | |
| 0.067 | 0.047 | 0.102 | Sphingosine 1-phosphate receptor 4 agonist | 0.102 0.024 CID_17005 | CID_17005 | |
| 0.039 | 0.019 | 0.039 | AMPA receptor agonist | 0.039 0.019 CID_17005 | ||
| 0.062 | 0.043 | 0.062 | Acetylcholine M2 receptor antagonist | |||
| 0.039 | 0.02 | 0.063 | Opioid delta receptor agonist | 0.063 0.009 CID_17005 | CID_17005 | |
| 0.057 | 0.039 | 0.081 | Neuropeptide agonist | 0.081 0.031 CID_17005 | CID_17005 | |
| 0.039 | 0.022 | 0.083 | Glutamate (mGluR3) antagonist | 0.083 0.005 CID_17005 | CID_17005 | |
| 0.143 | 0.126 | 0.252 | Succinate dehydrogenase inhibitor | 0.252 0.022 CID_17005 | CID_17005 | |
| 0.107 | 0.09 | 0.256 | Amylase inhibitor | 0.256 0.026 CID_17005 | CID_17005 | |
| 0.085 | 0.068 | 0.121 | Aminoacyl-tRNA synthetase inhibitor | 0.121 0.029 CID_17005 | CID_17005 | |
| 0.041 | 0.025 | 0.041 | GABA uptake inhibitor | |||
| 0.059 | 0.043 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.028 | 0.012 | 0.043 | Glutamate (mGluR1) agonist | 0.043 0.005 CID_17005 | CID_17005 | |
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.027 | 0.012 | 0.033 | Aminopeptidase P inhibitor | 0.033 0.008 CID_17005 | CID_17005 | |
| 0.053 | 0.037 | 0.095 | Ornithine carbamoyltransferase inhibitor | 0.095 0.017 CID_17005 | CID_17005 | |
| 0.04 | 0.025 | 0.041 | VCAM-1 antagonist | 0.041 0.021 CID_17005 | CID_17005 | |
| 0.091 | 0.076 | 0.141 | Anabolic | 0.141 0.023 CID_17005 | CID_17005 | |
| 0.04 | 0.025 | 0.041 | VCAM antagonist | 0.041 0.021 CID_17005 | CID_17005 | |
| 0.1 | 0.085 | 0.1 | Activin receptor-like kinase 4 inhibitor | |||
| 0.025 | 0.01 | 0.025 | Integrin beta5 antagonist | |||
| 0.142 | 0.127 | 0.215 | Non-steroidal antiinflammatory agent | 0.215 0.06 CID_17005 | CID_17005 | |
| 0.029 | 0.014 | 0.055 | Thyroid hormone agonist | 0.055 0.004 CID_17005 | CID_17005 | |
| 0.086 | 0.072 | 0.241 | Prolactin inhibitor | 0.241 0.005 CID_17005 | CID_17005 | |
| 0.052 | 0.038 | 0.094 | Opioid agonist | 0.094 0.014 CID_17005 | CID_17005 | |
| 0.037 | 0.022 | 0.059 | Tryptophan 5 hydroxylase inhibitor | 0.059 0.004 CID_17005 | CID_17005 | |
| 0.025 | 0.011 | 0.025 | ICAM 1 antagonist | 0.022 0.018 CID_17005 | ||
| 0.034 | 0.02 | 0.035 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 CID_17005 | CID_17005 | |
| 0.033 | 0.02 | 0.059 | Glutamate (mGluR3) agonist | 0.059 0.004 CID_17005 | CID_17005 | |
| 0.032 | 0.019 | 0.032 | Plasmepsin I inhibitor | |||
| 0.027 | 0.015 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_17005 | CID_17005 | |
| 0.122 | 0.111 | 0.203 | Hemostatic | 0.203 0.031 CID_17005 | CID_17005 | |
| 0.045 | 0.034 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.019 | 0.008 | 0.024 | Tryptophan hydroxylase 1 inhibitor | 0.024 0.004 CID_17005 | CID_17005 | |
| 0.099 | 0.089 | 0.131 | Alkylator | 0.131 0.059 CID_17005 | CID_17005 | |
| 0.195 | 0.185 | 0.331 | Apoptosis antagonist | 0.331 0.066 CID_17005 | CID_17005 | |
| 0.078 | 0.069 | 0.078 | Histamine H2 receptor antagonist | |||
| 0.076 | 0.067 | 0.076 | I kappa B kinase inhibitor | |||
| 0.044 | 0.035 | 0.074 | Beta adrenoreceptor agonist | 0.074 0.005 CID_17005 | CID_17005 | |
| 0.041 | 0.032 | 0.041 | GABA B receptor antagonist | |||
| 0.056 | 0.047 | 0.149 | Sphingosine kinase inhibitor | 0.149 0.004 CID_17005 | CID_17005 | |
| 0.06 | 0.051 | 0.078 | Neutrophil collagenase inhibitor | 0.078 0.033 CID_17005 | CID_17005 | |
| 0.035 | 0.026 | 0.045 | Glutamate (mGluR8) antagonist | 0.045 0.012 CID_17005 | CID_17005 | |
| 0.023 | 0.014 | 0.023 | Geranylgeranyltransferase inhibitor | |||
| 0.026 | 0.018 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.053 | 0.045 | 0.053 | Beta tubulin antagonist | 0.049 0.047 CID_17005 | ||
| 0.044 | 0.036 | 0.046 | Urokinase inhibitor | 0.046 0.034 CID_17005 | CID_17005 | |
| 0.09 | 0.082 | 0.172 | Ferrochelatase inhibitor | 0.172 0.03 CID_17005 | CID_17005 | |
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.029 | 0.023 | 0.029 | Phosphodiesterase 6B inhibitor | |||
| 0.09 | 0.083 | 0.104 | Glutamate (mGluR7) agonist | 0.104 0.053 CID_17005 | CID_17005 | |
| 0.05 | 0.044 | 0.054 | Leukotriene B4 antagonist | 0.054 0.036 CID_17005 | CID_17005 | |
| 0.057 | 0.051 | 0.057 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.022 | 0.016 | 0.022 | Bombesin agonist | |||
| 0.073 | 0.068 | 0.099 | MAP kinase kinase 7 inhibitor | 0.099 0.013 CID_17005 | CID_17005 | |
| 0.085 | 0.08 | 0.279 | Creatine kinase inhibitor | 0.279 0.004 CID_17005 | CID_17005 | |
| 0.073 | 0.068 | 0.175 | Carbonic anhydrase VI inhibitor | 0.175 0.016 CID_17005 | CID_17005 | |
| 0.085 | 0.081 | 0.106 | Interleukin 1 beta converting enzyme inhibitor | 0.106 0.05 CID_17005 | CID_17005 | |
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.023 | 0.019 | 0.023 | Phosphodiesterase 6G inhibitor | |||
| 0.023 | 0.019 | 0.023 | Phosphodiesterase 6H inhibitor | |||
| 0.05 | 0.047 | 0.152 | Sphingosine kinase 2 inhibitor | 0.152 0.004 CID_17005 | CID_17005 | |
| 0.05 | 0.047 | 0.059 | Angiotensin-converting enzyme inhibitor | 0.059 0.032 CID_17005 | CID_17005 | |
| 0.146 | 0.143 | 0.686 | Aldehyde oxidase inhibitor | 0.686 0.009 CID_17005 | CID_17005 | |
| 0.034 | 0.032 | 0.034 | Integrin alpha2 antagonist | |||
| 0.068 | 0.065 | 0.137 | Analgesic, opioid | 0.137 0.018 CID_17005 | CID_17005 | |
| 0.017 | 0.016 | 0.017 | Bombesin 3 receptor agonist | |||
| 0.021 | 0.019 | 0.021 | Dopamine autoreceptor agonist | |||
| 0.072 | 0.071 | 0.109 | Opioid kappa receptor antagonist | 0.109 0.029 CID_17005 | CID_17005 | |
| 0.051 | 0.05 | 0.051 | 5 Hydroxytryptamine 7 agonist | |||
| 0.014 | 0.013 | 0.015 | Dipeptidyl peptidase IX inhibitor | 0.015 0.011 CID_17005 | CID_17005 | |
| 0.055 | 0.054 | 0.055 | Protease activated receptor antagonist | |||
| 0.02 | 0.019 | 0.03 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_17005 | CID_17005 | |
| 0.025 | 0.025 | 0.033 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.033 0.011 CID_17005 | CID_17005 | |
| 0.175 | 0.176 | 0.326 | Transcription factor STAT inhibitor | 0.326 0.043 CID_17005 | CID_17005 | |
| 0.017 | 0.018 | 0.018 | Integrin alpha4beta7 antagonist | 0.018 0.017 CID_17005 | CID_17005 | |
| 0.036 | 0.037 | 0.065 | Oxytocin agonist | 0.065 0.013 CID_17005 | CID_17005 | |
| 0.038 | 0.039 | 0.045 | HIV-1 protease inhibitor | 0.045 0.027 CID_17005 | CID_17005 | |
| 0.046 | 0.048 | 0.054 | Cathepsin D inhibitor | 0.054 0.038 CID_17005 | CID_17005 | |
| 0.128 | 0.13 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.153 0.035 CID_17005 | CID_17005 | |
| 0.037 | 0.04 | 0.108 | Sphingosine kinase 1 inhibitor | 0.108 0.004 CID_17005 | CID_17005 | |
| 0.05 | 0.054 | 0.12 | Carbonic anhydrase stimulant | 0.12 0.014 CID_17005 | CID_17005 | |
| 0.047 | 0.05 | 0.093 | Aminopeptidase microsomal inhibitor | 0.093 0.019 CID_17005 | CID_17005 | |
| 0.047 | 0.051 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.043 CID_17005 | CID_17005 | |
| 0.014 | 0.018 | 0.024 | Aminopeptidase A inhibitor | 0.024 0.008 CID_17005 | CID_17005 | |
| 0.042 | 0.047 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | 0.045 0.035 CID_17005 | CID_17005 | |
| 0.028 | 0.033 | 0.052 | Fumarate hydratase inhibitor | 0.052 0.013 CID_17005 | CID_17005 | |
| 0.062 | 0.067 | 0.092 | Secretase beta inhibitor | 0.092 0.023 CID_17005 | CID_17005 | |
| 0.037 | 0.042 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.042 0.033 CID_17005 | CID_17005 | |
| 0.026 | 0.033 | 0.044 | Calcitonin receptor agonist | 0.044 0.018 CID_17005 | CID_17005 | |
| 0.014 | 0.021 | 0.021 | Telomerase stimulant | 0.021 0.006 CID_17005 | CID_17005 | |
| 0.042 | 0.05 | 0.074 | Bombesin 2 receptor antagonist | 0.074 0.018 CID_17005 | CID_17005 | |
| 0.036 | 0.045 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 CID_17005 | CID_17005 | |
| 0.054 | 0.063 | 0.131 | Phosphofructokinase-1 inhibitor | 0.131 0.022 CID_17005 | CID_17005 | |
| 0.017 | 0.026 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 CID_17005 | CID_17005 | |
| 0.055 | 0.064 | 0.114 | Beta adrenoreceptor antagonist | 0.114 0.012 CID_17005 | CID_17005 | |
| 0.017 | 0.026 | 0.024 | VLA-4 antagonist | 0.024 0.019 CID_17005 | CID_17005 | |
| 0.028 | 0.038 | 0.031 | Calpain 1 inhibitor | 0.031 0.029 CID_17005 | CID_17005 | |
| 0.067 | 0.077 | 0.077 | 5 Hydroxytryptamine 2C antagonist | 0.077 0.064 CID_17005 | CID_17005 | |
| 0.128 | 0.138 | 0.296 | Interleukin antagonist | 0.296 0.049 CID_17005 | CID_17005 | |
| 0.043 | 0.054 | 0.047 | CD45 antagonist | 0.047 0.043 CID_17005 | CID_17005 | |
| 0.033 | 0.045 | 0.037 | Neurokinin 2 agonist | 0.037 0.035 CID_17005 | CID_17005 | |
| 0.042 | 0.054 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.025 CID_17005 | CID_17005 | |
| 0.037 | 0.05 | 0.058 | Glutamate (mGluR4) antagonist | 0.058 0.015 CID_17005 | CID_17005 | |
| 0.108 | 0.121 | 0.151 | Diuretic | 0.151 0.077 CID_17005 | CID_17005 | |
| 0.048 | 0.062 | 0.067 | Kallikrein 1 inhibitor | 0.067 0.026 CID_17005 | CID_17005 | |
| 0.078 | 0.092 | 0.299 | Monophenol monooxygenase inhibitor | 0.299 0.018 CID_17005 | CID_17005 | |
| 0.058 | 0.073 | 0.147 | Cathepsin G inhibitor | 0.147 0.021 CID_17005 | CID_17005 | |
| 0.039 | 0.054 | 0.048 | Bombesin antagonist | 0.048 0.032 CID_17005 | CID_17005 | |
| 0.034 | 0.049 | 0.04 | Plasmin inhibitor | 0.04 0.038 CID_17005 | CID_17005 | |
| 0.038 | 0.053 | 0.041 | Dipeptidyl peptidase IV inhibitor | 0.041 0.039 CID_17005 | CID_17005 | |
| 0.033 | 0.049 | 0.069 | Aminopeptidase N inhibitor | 0.069 0.02 CID_17005 | CID_17005 | |
| 0.063 | 0.08 | 0.095 | Macrophage migration inhibitory factor inhibitor | 0.095 0.038 CID_17005 | CID_17005 | |
| 0.027 | 0.043 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.026 CID_17005 | CID_17005 | |
| 0.007 | 0.024 | 0.025 | Glutamate (mGluR6) agonist | 0.025 0.004 CID_17005 | CID_17005 | |
| 0.063 | 0.081 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.04 CID_17005 | CID_17005 | |
| 0.034 | 0.051 | 0.041 | GHS receptor agonist | 0.041 0.032 CID_17005 | CID_17005 | |
| 0.044 | 0.062 | 0.09 | Vanilloid 2 antagonist | 0.09 0.007 CID_17005 | CID_17005 | |
| 0.026 | 0.046 | 0.043 | Complement C3a chemotactic receptor antagonist | 0.043 0.031 CID_17005 | CID_17005 | |
| 0.09 | 0.111 | 0.146 | Photosensitizer | 0.146 0.034 CID_17005 | CID_17005 | |
| 0.118 | 0.139 | 0.239 | Interferon gamma antagonist | 0.239 0.03 CID_17005 | CID_17005 | |
| 0.081 | 0.103 | 0.338 | Cystathionine beta-synthase inhibitor | 0.338 0.007 CID_17005 | CID_17005 | |
| 0.038 | 0.06 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 CID_17005 | CID_17005 | |
| 0.054 | 0.077 | 0.121 | Beta 3 adrenoreceptor antagonist | 0.121 0.009 CID_17005 | CID_17005 | |
| 0.038 | 0.061 | 0.07 | Plasminogen activator inhibitor | 0.07 0.032 CID_17005 | CID_17005 | |
| 0.029 | 0.052 | 0.044 | Growth hormone release inhibitor | 0.044 0.027 CID_17005 | CID_17005 | |
| 0.027 | 0.05 | 0.052 | Toll-Like receptor 2 agonist | 0.052 0.022 CID_17005 | CID_17005 | |
| 0.004 | 0.028 | 0.01 | Thyroid hormone beta agonist | 0.01 0.005 CID_17005 | CID_17005 | |
| 0.072 | 0.096 | 0.129 | NADH dehydrogenase inhibitor | 0.129 0.024 CID_17005 | CID_17005 | |
| 0.052 | 0.078 | 0.093 | Sirtuin 1 inhibitor | 0.093 0.026 CID_17005 | CID_17005 | |
| 0.033 | 0.059 | 0.107 | Ribonucleoside-diphosphate reductase inhibitor | 0.107 0.018 CID_17005 | CID_17005 | |
| 0.066 | 0.092 | 0.132 | Glutathione S-transferase inhibitor | 0.132 0.017 CID_17005 | CID_17005 | |
| 0.059 | 0.085 | 0.114 | Glycine receptor agonist | 0.114 0.014 CID_17005 | CID_17005 | |
| 0.01 | 0.037 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 CID_17005 | CID_17005 | |
| 0.083 | 0.11 | 0.15 | Histone deacetylase class III inhibitor | 0.15 0.044 CID_17005 | CID_17005 | |
| 0.032 | 0.061 | 0.106 | Ribonucleotide reductase inhibitor | 0.106 0.019 CID_17005 | CID_17005 | |
| 0.018 | 0.047 | 0.066 | Arginase inhibitor | 0.066 0.009 CID_17005 | CID_17005 | |
| 0.072 | 0.102 | 0.123 | Estrogen-related receptor beta agonist | 0.123 0.009 CID_17005 | CID_17005 | |
| 0.069 | 0.1 | 0.153 | Bronchodilator | 0.153 0.03 CID_17005 | CID_17005 | |
| 0.053 | 0.084 | 0.071 | Thrombin inhibitor | 0.071 0.053 CID_17005 | CID_17005 | |
| 0.03 | 0.062 | 0.05 | Neurotensin receptor antagonist | 0.05 0.028 CID_17005 | CID_17005 | |
| 0.118 | 0.15 | 0.15 | Tumour necrosis factor antagonist | 0.15 0.1 CID_17005 | CID_17005 | |
| 0.062 | 0.094 | 0.12 | Histamine N-methyltransferase inhibitor | 0.12 0.03 CID_17005 | CID_17005 | |
| 0.097 | 0.129 | 0.19 | Protein kinase stimulant | 0.19 0.045 CID_17005 | CID_17005 | |
| 0.03 | 0.063 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.02 CID_17005 | CID_17005 | |
| 0.023 | 0.056 | 0.033 | Somatostatin 5 agonist | 0.033 0.027 CID_17005 | CID_17005 | |
| 0.04 | 0.076 | 0.057 | Bombesin 3 receptor antagonist | 0.057 0.036 CID_17005 | CID_17005 | |
| 0.009 | 0.047 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 CID_17005 | CID_17005 | |
| 0.016 | 0.055 | 0.03 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.022 CID_17005 | CID_17005 | |
| 0.044 | 0.083 | 0.103 | Purinergic P2X1 antagonist | 0.103 0.015 CID_17005 | CID_17005 | |
| 0.014 | 0.054 | 0.027 | Lysine carboxypeptidase inhibitor | 0.027 0.019 CID_17005 | CID_17005 | |
| 0.011 | 0.051 | 0.032 | Somatostatin 5 antagonist | 0.032 0.022 CID_17005 | CID_17005 | |
| 0.066 | 0.108 | 0.129 | Urease inhibitor | 0.129 0.037 CID_17005 | CID_17005 | |
| 0.025 | 0.068 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.031 CID_17005 | CID_17005 | |
| 0.04 | 0.083 | 0.067 | Epithelial sodium channel blocker | 0.067 0.021 CID_17005 | CID_17005 | |
| 0.087 | 0.13 | 0.24 | Toll-Like receptor 2 antagonist | 0.24 0.011 CID_17005 | CID_17005 | |
| 0.018 | 0.063 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 CID_17005 | CID_17005 | |
| 0.078 | 0.122 | 0.154 | GABA C receptor antagonist | 0.154 0.028 CID_17005 | CID_17005 | |
| 0.089 | 0.134 | 0.131 | NADPH oxidase inhibitor | 0.131 0.07 CID_17005 | CID_17005 | |
| 0.044 | 0.089 | 0.092 | NMDA receptor agonist | 0.092 0.022 CID_17005 | CID_17005 | |
| 0.04 | 0.085 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | 0.078 0.018 CID_17005 | CID_17005 | |
| 0.073 | 0.118 | 0.125 | GABA C receptor rho-1 antagonist | 0.125 0.036 CID_17005 | CID_17005 | |
| 0.037 | 0.083 | 0.074 | Biliverdin reductase inhibitor | 0.074 0.029 CID_17005 | CID_17005 | |
| 0.049 | 0.096 | 0.064 | Trypsin inhibitor | 0.064 0.039 CID_17005 | CID_17005 | |
| 0.066 | 0.113 | 0.115 | Triose-phosphate isomerase inhibitor | 0.115 0.035 CID_17005 | CID_17005 | |
| 0.032 | 0.08 | 0.056 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 CID_17005 | CID_17005 | |
| 0.038 | 0.087 | 0.06 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.06 0.04 CID_17005 | CID_17005 | |
| 0.033 | 0.082 | 0.15 | Alcohol oxidase inhibitor | 0.15 0.01 CID_17005 | CID_17005 | |
| 0.039 | 0.088 | 0.069 | Matrix metalloproteinase inhibitor | 0.069 0.045 CID_17005 | CID_17005 | |
| 0.034 | 0.084 | 0.054 | Aconitate hydratase inhibitor | 0.054 0.032 CID_17005 | CID_17005 | |
| 0.036 | 0.087 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.043 CID_17005 | CID_17005 | |
| 0.108 | 0.159 | 0.173 | Nitric oxide antagonist | 0.173 0.08 CID_17005 | CID_17005 | |
| 0.03 | 0.081 | 0.091 | Beta 2 adrenoreceptor antagonist | 0.091 0.009 CID_17005 | CID_17005 | |
| 0.026 | 0.077 | 0.057 | Matrix metalloproteinase 1 inhibitor | 0.057 0.033 CID_17005 | CID_17005 | |
| 0.087 | 0.14 | 0.13 | Nav1.2 sodium channel blocker | 0.13 0.072 CID_17005 | CID_17005 | |
| 0.026 | 0.08 | 0.035 | Adenosine uptake inhibitor | 0.035 0.022 CID_17005 | CID_17005 | |
| 0.066 | 0.12 | 0.132 | UDP-glucose 4-epimerase inhibitor | 0.132 0.036 CID_17005 | CID_17005 | |
| 0.014 | 0.068 | 0.041 | Sirtuin 2 inhibitor | 0.041 0.017 CID_17005 | CID_17005 | |
| 0.034 | 0.088 | 0.066 | Neuraminidase inhibitor | 0.066 0.037 CID_17005 | CID_17005 | |
| 0.011 | 0.067 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_17005 | CID_17005 | |
| 0.172 | 0.228 | 0.34 | Immunosuppressant | 0.34 0.092 CID_17005 | CID_17005 | |
| 0.086 | 0.142 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 CID_17005 | CID_17005 | |
| 0.012 | 0.068 | 0.034 | Beta 1 adrenoreceptor agonist | 0.034 0.006 CID_17005 | CID_17005 | |
| 0.005 | 0.062 | 0.02 | Kainate receptor 1 antagonist | 0.02 0.015 CID_17005 | CID_17005 | |
| 0.091 | 0.148 | 0.116 | Antibacterial (Helicobacter pylori) | 0.116 0.087 CID_17005 | CID_17005 | |
| 0.094 | 0.155 | 0.166 | Neurotrophic factor | 0.166 0.046 CID_17005 | CID_17005 | |
| 0.05 | 0.112 | 0.088 | Metalloproteinase-2 inhibitor | 0.088 0.045 CID_17005 | CID_17005 | |
| 0.01 | 0.072 | 0.028 | Estrogen-related receptor gamma agonist | 0.028 0.004 CID_17005 | CID_17005 | |
| 0.016 | 0.079 | 0.047 | Cathepsin L2 inhibitor | 0.047 0.024 CID_17005 | CID_17005 | |
| 0.096 | 0.158 | 0.148 | Mannose-6-phosphate isomerase inhibitor | 0.148 0.066 CID_17005 | CID_17005 | |
| 0.016 | 0.079 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 CID_17005 | CID_17005 | |
| 0.088 | 0.153 | 0.15 | Transcription factor STAT6 inhibitor | 0.15 0.023 CID_17005 | CID_17005 | |
| 0.076 | 0.141 | 0.109 | Caspase 3 inhibitor | 0.109 0.077 CID_17005 | CID_17005 | |
| 0.144 | 0.21 | 0.234 | Lipoxygenase inhibitor | 0.234 0.111 CID_17005 | CID_17005 | |
| 0.097 | 0.163 | 0.16 | Insulin secretagoues | 0.16 0.064 CID_17005 | CID_17005 | |
| 0.023 | 0.09 | 0.073 | NMDA receptor subunit 3B antagonist | 0.073 0.015 CID_17005 | CID_17005 | |
| 0.041 | 0.108 | 0.182 | Porphobilinogen synthase inhibitor | 0.182 0.014 CID_17005 | CID_17005 | |
| 0.029 | 0.097 | 0.095 | Beta 1 adrenoreceptor antagonist | 0.095 0.011 CID_17005 | CID_17005 | |
| 0.127 | 0.197 | 0.387 | Antioxidant | 0.387 0.037 CID_17005 | CID_17005 | |
| 0.022 | 0.097 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.017 CID_17005 | CID_17005 | |
| 0.064 | 0.139 | 0.101 | D-Ala-D-Ala ligase inhibitor | 0.101 0.028 CID_17005 | CID_17005 | |
| 0.019 | 0.095 | 0.108 | Glycine transporter 2 inhibitor | 0.108 0.012 CID_17005 | CID_17005 | |
| 0.172 | 0.248 | 0.349 | GABA C receptor rho-3 antagonist | 0.349 0.086 CID_17005 | CID_17005 | |
| 0.02 | 0.096 | 0.038 | Erythropoietin receptor agonist | 0.038 0.031 CID_17005 | CID_17005 | |
| 0.118 | 0.195 | 0.434 | Free radical scavenger | 0.434 0.024 CID_17005 | CID_17005 | |
| 0.02 | 0.099 | 0.048 | Antimetabolite | 0.048 0.033 CID_17005 | CID_17005 | |
| 0.147 | 0.226 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | 0.182 0.176 CID_17005 | CID_17005 | |
| 0.115 | 0.195 | 0.17 | Platelet antagonist | 0.17 0.126 CID_17005 | CID_17005 | |
| 0.018 | 0.1 | 0.088 | NMDA 2A receptor antagonist | 0.088 0.017 CID_17005 | CID_17005 | |
| 0.038 | 0.12 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.085 0.046 CID_17005 | CID_17005 | |
| 0.047 | 0.13 | 0.079 | Metalloproteinase-9 inhibitor | 0.079 0.044 CID_17005 | CID_17005 | |
| 0.013 | 0.096 | 0.03 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 CID_17005 | CID_17005 | |
| 0.088 | 0.172 | 0.193 | Phospholipase A2 inhibitor | 0.193 0.047 CID_17005 | CID_17005 | |
| 0.011 | 0.095 | 0.051 | Kainate receptor 2 antagonist | 0.051 0.016 CID_17005 | CID_17005 | |
| 0.09 | 0.175 | 0.379 | Amyloid beta aggregation inhibitor | 0.379 0.028 CID_17005 | CID_17005 | |
| 0.02 | 0.105 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.026 CID_17005 | CID_17005 | |
| 0.005 | 0.092 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.01 CID_17005 | CID_17005 | |
| 0.015 | 0.104 | 0.07 | NMDA receptor subunit 3A antagonist | 0.07 0.014 CID_17005 | CID_17005 | |
| 0.007 | 0.096 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 CID_17005 | CID_17005 | |
| 0.067 | 0.157 | 0.1 | Glutamate release inhibitor | 0.1 0.042 CID_17005 | CID_17005 | |
| 0.09 | 0.182 | 0.189 | Arachidonic acid antagonist | 0.189 0.044 CID_17005 | CID_17005 | |
| 0.1 | 0.194 | 0.249 | DNA methylase inhibitor | 0.249 0.049 CID_17005 | CID_17005 | |
| 0.061 | 0.158 | 0.121 | Protein kinase C zeta inhibitor | 0.121 0.032 CID_17005 | CID_17005 | |
| 0.052 | 0.15 | 0.069 | Vanilloid 4 agonist | 0.069 0.067 CID_17005 | CID_17005 | |
| 0.072 | 0.17 | 0.141 | TRPA1 agonist | 0.141 0.038 CID_17005 | CID_17005 | |
| 0.071 | 0.17 | 0.232 | Lipid peroxidase inhibitor | 0.232 0.031 CID_17005 | CID_17005 | |
| 0.041 | 0.142 | 0.054 | Leukotriene C antagonist | 0.054 0.048 CID_17005 | CID_17005 | |
| 0.029 | 0.133 | 0.095 | Dopamine agonist | 0.095 0.029 CID_17005 | CID_17005 | |
| 0.034 | 0.138 | 0.116 | Carbonic anhydrase XIII inhibitor | 0.116 0.031 CID_17005 | CID_17005 | |
| 0.167 | 0.272 | 0.305 | Antibacterial | 0.305 0.131 CID_17005 | CID_17005 | |
| 0.092 | 0.198 | 0.231 | DNA methyltransferase I inhibitor | 0.231 0.055 CID_17005 | CID_17005 | |
| 0.09 | 0.197 | 0.162 | Platelet adhesion inhibitor | 0.162 0.094 CID_17005 | CID_17005 | |
| 0.101 | 0.209 | 0.141 | Antipruritic | 0.141 0.106 CID_17005 | CID_17005 | |
| 0.016 | 0.125 | 0.078 | Carbonic anhydrase VB inhibitor | 0.078 0.023 CID_17005 | CID_17005 | |
| 0.013 | 0.124 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.013 CID_17005 | CID_17005 | |
| 0.057 | 0.168 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.042 CID_17005 | CID_17005 | |
| 0.015 | 0.127 | 0.041 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.03 CID_17005 | CID_17005 | |
| 0.021 | 0.134 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 CID_17005 | CID_17005 | |
| 0.041 | 0.153 | 0.143 | NMDA receptor antagonist | 0.143 0.027 CID_17005 | CID_17005 | |
| 0.027 | 0.144 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.01 CID_17005 | CID_17005 | |
| 0.032 | 0.149 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 CID_17005 | CID_17005 | |
| 0.024 | 0.142 | 0.084 | Selectin antagonist | 0.084 0.035 CID_17005 | CID_17005 | |
| 0.023 | 0.141 | 0.059 | NMDA receptor glycine site agonist | 0.059 0.047 CID_17005 | CID_17005 | |
| 0.03 | 0.149 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 CID_17005 | CID_17005 | |
| 0.015 | 0.135 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.014 CID_17005 | CID_17005 | |
| 0.021 | 0.148 | 0.046 | Glutamate (mGluR group III) agonist | 0.046 0.027 CID_17005 | CID_17005 | |
| 0.047 | 0.176 | 0.205 | HIV-1 integrase (Overall Integration) inhibitor | 0.205 0.011 CID_17005 | CID_17005 | |
| 0.038 | 0.17 | 0.074 | Protein kinase A inhibitor | 0.074 0.066 CID_17005 | CID_17005 | |
| 0.179 | 0.314 | 0.4 | Calcium channel L-type activator | 0.4 0.081 CID_17005 | CID_17005 | |
| 0.145 | 0.283 | 0.274 | Antiobesity | 0.274 0.136 CID_17005 | CID_17005 | |
| 0.016 | 0.154 | 0.083 | NMDA 2C receptor antagonist | 0.083 0.023 CID_17005 | CID_17005 | |
| 0.062 | 0.202 | 0.109 | Cytokine production inhibitor | 0.109 0.101 CID_17005 | CID_17005 | |
| 0.213 | 0.355 | 0.272 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.272 0.253 CID_17005 | CID_17005 | |
| 0.036 | 0.179 | 0.059 | Interferon inducer | 0.059 0.057 CID_17005 | CID_17005 | |
| 0.008 | 0.151 | 0.032 | Dopamine D1 agonist | 0.032 0.008 CID_17005 | CID_17005 | |
| 0.038 | 0.185 | 0.072 | Interferon agonist | 0.072 0.066 CID_17005 | CID_17005 | |
| 0.025 | 0.177 | 0.076 | Carbonic anhydrase VA inhibitor | 0.076 0.04 CID_17005 | CID_17005 | |
| 0.038 | 0.195 | 0.145 | Alcohol dehydrogenase inhibitor | 0.145 0.022 CID_17005 | CID_17005 | |
| 0.021 | 0.18 | 0.074 | Carbonic anhydrase V inhibitor | 0.074 0.039 CID_17005 | CID_17005 | |
| 0.149 | 0.309 | 0.282 | Calcium channel activator | 0.282 0.11 CID_17005 | CID_17005 | |
| 0.016 | 0.179 | 0.056 | Carbonic anhydrase XIV inhibitor | 0.056 0.027 CID_17005 | CID_17005 | |
| 0.065 | 0.232 | 0.142 | Anticoagulant | 0.142 0.087 CID_17005 | CID_17005 | |
| 0.08 | 0.248 | 0.13 | GABA C receptor rho-2 antagonist | 0.13 0.105 CID_17005 | CID_17005 | |
| 0.059 | 0.231 | 0.143 | Aldehyde dehydrogenase inhibitor | 0.143 0.052 CID_17005 | CID_17005 | |
| 0.047 | 0.219 | 0.117 | Bile acid receptor antagonist | 0.117 0.022 CID_17005 | CID_17005 | |
| 0.052 | 0.225 | 0.15 | Alkaline phosphatase inhibitor | 0.15 0.06 CID_17005 | CID_17005 | |
| 0.06 | 0.237 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.164 0.067 CID_17005 | CID_17005 | |
| 0.027 | 0.208 | 0.07 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 CID_17005 | CID_17005 | |
| 0.124 | 0.306 | 0.224 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.224 0.131 CID_17005 | CID_17005 | |
| 0.056 | 0.243 | 0.083 | CC chemokine 5 receptor agonist | 0.083 0.053 CID_17005 | CID_17005 | |
| 0.042 | 0.235 | 0.065 | Prolactin release inhibitor | 0.065 0.034 CID_17005 | CID_17005 | |
| 0.027 | 0.22 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.04 CID_17005 | CID_17005 | |
| 0.015 | 0.209 | 0.04 | Dihydroorotase inhibitor | 0.04 0.038 CID_17005 | CID_17005 | |
| 0.044 | 0.242 | 0.108 | Xanthine oxidase inhibitor | 0.108 0.054 CID_17005 | CID_17005 | |
| 0.06 | 0.26 | 0.093 | Folate antagonist | 0.093 0.079 CID_17005 | CID_17005 | |
| 0.041 | 0.242 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.059 CID_17005 | CID_17005 | |
| 0.038 | 0.24 | 0.132 | Cholesterol synthesis inhibitor | 0.132 0.055 CID_17005 | CID_17005 | |
| 0.046 | 0.256 | 0.098 | Beta amyloid protein antagonist | 0.098 0.093 CID_17005 | CID_17005 | |
| 0.022 | 0.242 | 0.048 | Squalene epoxidase inhibitor | 0.048 0.038 CID_17005 | CID_17005 | |
| 0.026 | 0.275 | 0.112 | 5-Lipoxygenase inhibitor | 0.112 0.055 CID_17005 | CID_17005 | |
| 0.025 | 0.282 | 0.078 | Potassium channel (Ca-activated) activator | 0.078 0.077 CID_17005 | CID_17005 | |
| 0.035 | 0.292 | 0.129 | Protein kinase C gamma inhibitor | 0.129 0.045 CID_17005 | CID_17005 | |
| 0.013 | 0.277 | 0.085 | HIV-1 integrase (3'-Processing) inhibitor | 0.085 0.031 CID_17005 | CID_17005 | |
| 0.017 | 0.286 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 CID_17005 | CID_17005 | |
| 0.07 | 0.34 | 0.208 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.208 0.085 CID_17005 | CID_17005 | |
| 0.013 | 0.284 | 0.088 | Maillard reaction inhibitor | 0.088 0.021 CID_17005 | CID_17005 | |
| 0.019 | 0.296 | 0.102 | Protein-tyrosine phosphatase 1B inhibitor | 0.102 0.076 CID_17005 | CID_17005 | |
| 0.068 | 0.351 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.059 CID_17005 | CID_17005 | |
| 0.006 | 0.298 | 0.086 | NMDA 2 receptor antagonist | 0.086 0.04 CID_17005 | CID_17005 | |
| 0.009 | 0.314 | 0.057 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 CID_17005 | CID_17005 | |
| 0.028 | 0.334 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 CID_17005 | CID_17005 | |
| 0.044 | 0.396 | 0.154 | Interleukin 4 antagonist | 0.154 0.046 CID_17005 | CID_17005 | |
| 0.017 | 0.406 | 0.06 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.044 CID_17005 | CID_17005 | |
| 0.031 | 0.429 | 0.167 | DNA polymerase I inhibitor | 0.167 0.041 CID_17005 | CID_17005 | |
| 0.023 | 0.437 | 0.175 | Chelator | 0.175 0.029 CID_17005 | CID_17005 | |
| 0.015 | 0.43 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.023 CID_17005 | CID_17005 | |
| 0.022 | 0.444 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.055 CID_17005 | CID_17005 | |
| 0.028 | 0.501 | 0.106 | Toll-Like receptor 4 antagonist | 0.106 0.06 CID_17005 | CID_17005 | |
| 0.025 | 0.51 | 0.115 | Estrogen antagonist | 0.115 0.064 CID_17005 | CID_17005 | |
| 0.014 | 0.522 | 0.222 | M18 aspartyl aminopeptidase inhibitor | 0.222 0.027 CID_17005 | CID_17005 | |
| 0.054 | 0.623 | 0.324 | Cyclophilin D inhibitor | 0.324 0.143 CID_17005 | CID_17005 | |
| 0.052 | 0.627 | 0.297 | Sodium/bile acid cotransporter inhibitor | 0.297 0.082 CID_17005 | CID_17005 | |
| 0.004 | 0.59 | 0.059 | Catechol O-methyltransferase inhibitor | 0.059 0.007 CID_17005 | CID_17005 | |
| 0.044 | 0.68 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.161 0.084 CID_17005 | CID_17005 | |
| 0.033 | 0.685 | 0.12 | NOS3 expression enhancer | 0.12 0.115 CID_17005 | CID_17005 | |
| 0.005 | 0.716 | 0.065 | HIV-1 integrase inhibitor | 0.065 0.056 CID_17005 | CID_17005 | |
| 0.014 | 0.74 | 0.139 | Farnesoid X receptor antagonist | 0.139 0.067 CID_17005 | CID_17005 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |